SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-007020
Filing Date
2015-08-11
Accepted
2015-08-11 16:33:10
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q abio-10q_20150630.htm 10-Q 1279627
2 EX-31.1 abio-ex311_8.htm EX-31.1 8508
3 EX-31.2 abio-ex312_9.htm EX-31.2 8457
4 EX-32.1 abio-ex321_6.htm EX-32.1 11316
  Complete submission text file 0001564590-15-007020.txt   3684803

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT abio-20150630.xml EX-101.INS 594126
6 XBRL TAXONOMY EXTENSION SCHEMA abio-20150630.xsd EX-101.SCH 34215
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20150630_cal.xml EX-101.CAL 24557
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20150630_def.xml EX-101.DEF 77742
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20150630_lab.xml EX-101.LAB 257391
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20150630_pre.xml EX-101.PRE 178357
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 151044252
SIC: 2835 In Vitro & In Vivo Diagnostic Substances